Clinical Trial Update: Olfactory Disfunction and Co-ultraPEALut [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on olfactory dysfunction (anosmia) related to COVID-19 evaluating Co-ultraPEALut.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anosmia
• COVID-19 Related Olfactory Dysfunction

Drugs mentioned

• Co-ultraPEALut (Co-ultraPEALut)

Snippet

Sponsor: University Of Perugia | Conditions: Anosmia, Covid19 | Phase 4 | Status: COMPLETED